HomeABUS • NASDAQ
add
Arbutus Biopharma Corp
$4.48
Makalipas ang Oras ng Trabaho:(0.22%)+0.0098
$4.49
Sarado: Abr 2, 6:13:36 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$4.52
Sakop ng araw
$4.37 - $4.54
Sakop ng taon
$2.71 - $5.10
Market cap
875.74M USD
Average na Volume
2.66M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.05M | -33.23% |
Gastos sa pagpapatakbo | 3.69M | -21.71% |
Net na kita | -3.76M | 70.03% |
Net profit margin | -357.37 | 55.11% |
Kita sa bawat share | — | — |
EBITDA | -7.63M | 34.28% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 91.47M | -25.40% |
Kabuuang asset | 94.62M | -28.16% |
Kabuuang sagutin | 18.04M | -47.46% |
Kabuuang equity | 76.58M | — |
Natitirang share | 195.48M | — |
Presyo para makapag-book | 11.30 | — |
Return on assets | -19.87% | — |
Return on capital | -23.48% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -3.76M | 70.03% |
Cash mula sa mga operasyon | -4.68M | 54.63% |
Cash mula sa pag-invest | -1.36M | -110.15% |
Cash mula sa financing | 1.64M | 15.41% |
Net change in cash | -4.40M | -198.13% |
Malayang cash flow | -1.95M | 77.37% |
Tungkol
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Itinatag
2007
Headquarters
Website
Mga Empleyado
19
